Your session is about to expire
← Back to Search
Automated Management for Sleep Apnea
Study Summary
This trial aims to help Spanish-speaking Hispanics with Obstructive Sleep Apnoea (OSA) to better adhere to positive airway pressure (PAP) treatment. A tele-management intervention will be used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need extra oxygen or a device to help me breathe.I have a sleep disorder diagnosed other than OSA, confirmed by a sleep study.I am pregnant and have been referred for sleep apnea treatment.I am 18 years old or older.You identify yourself as Hispanic.I am planning to have or have been referred for bariatric surgery.I am referred for and agree to undergo PAP treatment.I am either male or female.I have moderate to severe sleep apnea with an AHI of 15 or more.
- Group 1: Automated Management (AM)
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open enrollments for this clinical trial?
"According to the clinicaltrials.gov database, this trial is no longer accepting patients; with initial posting date being on 1/10/2023 and last edited on 11/8/2022. Fortunately, there are 282 other trials currently enrolling participants for their respective studies."
How many sites are implementing this research endeavor?
"Currently, 4 medical institutions are recruiting patients for this trial: Geisinger in Danville, University of Pennsylvania in Philadelphia, Kaiser Permanent Southern California in Fontana, and another four sites."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger